{"title":"Treatment of congenital syphilis.","authors":"J W Budell","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Although penicillin remains the drug of choice for congenital syphilis, the optimal regimen has not been established. The published clinical trials were completed before the development of repository preparations such as benzathine penicillin. Consequently, current therapy must be derived from available clinical and pharmacologic data.</p>","PeriodicalId":76030,"journal":{"name":"Journal of the American Venereal Disease Association","volume":"3 2 Pt 2","pages":"168-71"},"PeriodicalIF":0.0000,"publicationDate":"1976-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Venereal Disease Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Although penicillin remains the drug of choice for congenital syphilis, the optimal regimen has not been established. The published clinical trials were completed before the development of repository preparations such as benzathine penicillin. Consequently, current therapy must be derived from available clinical and pharmacologic data.